LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 207 filers reported holding LIGAND PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.55 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $80,404,551 | -17.1% | 1,341,873 | -0.2% | 0.05% | -11.7% |
| Q2 2023 | $96,941,936 | +4.6% | 1,344,555 | +6.7% | 0.06% | -1.6% |
| Q1 2023 | $92,676,514 | +10.5% | 1,259,885 | +0.4% | 0.06% | +1.7% |
| Q4 2022 | $83,852,041 | -22.9% | 1,255,273 | -50.3% | 0.06% | -25.9% |
| Q3 2022 | $108,808,700 | -12.2% | 2,524,666 | +81.7% | 0.08% | -4.7% |
| Q2 2022 | $123,970,000 | -20.7% | 1,389,488 | +0.0% | 0.08% | +13.3% |
| Q1 2022 | $156,256,000 | -29.8% | 1,389,067 | -3.6% | 0.08% | -19.4% |
| Q4 2021 | $222,589,000 | +9.2% | 1,441,085 | -1.5% | 0.09% | +4.5% |
| Q3 2021 | $203,811,000 | +7.6% | 1,462,900 | +1.3% | 0.09% | +9.9% |
| Q2 2021 | $189,467,000 | -1.2% | 1,444,221 | +14.8% | 0.08% | -8.0% |
| Q1 2021 | $191,751,000 | +19.6% | 1,257,797 | -22.0% | 0.09% | +17.3% |
| Q4 2020 | $160,350,000 | +4.7% | 1,612,369 | +0.4% | 0.08% | -6.2% |
| Q3 2020 | $153,088,000 | -14.7% | 1,606,041 | +0.1% | 0.08% | -20.8% |
| Q2 2020 | $179,516,000 | +55.1% | 1,604,974 | +0.8% | 0.10% | +26.2% |
| Q1 2020 | $115,740,000 | -38.9% | 1,591,582 | -12.4% | 0.08% | -17.5% |
| Q4 2019 | $189,544,000 | +21.6% | 1,817,474 | +16.1% | 0.10% | +15.5% |
| Q3 2019 | $155,882,000 | -11.5% | 1,566,022 | +1.5% | 0.08% | -12.5% |
| Q2 2019 | $176,096,000 | +1.1% | 1,542,670 | +11.4% | 0.10% | -1.0% |
| Q1 2019 | $174,117,000 | +29.8% | 1,385,066 | +40.1% | 0.10% | +12.8% |
| Q4 2018 | $134,194,000 | -45.7% | 988,900 | +9.9% | 0.09% | -34.8% |
| Q3 2018 | $247,065,000 | +28.6% | 900,087 | -2.9% | 0.13% | +21.1% |
| Q2 2018 | $192,068,000 | +33.3% | 927,101 | +6.3% | 0.11% | +28.2% |
| Q1 2018 | $144,038,000 | +15.0% | 872,111 | -4.6% | 0.08% | +10.4% |
| Q4 2017 | $125,207,000 | +21.9% | 914,385 | +21.2% | 0.08% | +16.7% |
| Q3 2017 | $102,751,000 | +42.1% | 754,692 | +26.7% | 0.07% | +34.7% |
| Q2 2017 | $72,293,000 | – | 595,491 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knott David M Jr | 115,000 | $6,891 | 2.63% |
| VILLERE ST DENIS J & CO LLC | 438,161 | $26,254,607 | 2.24% |
| RICE HALL JAMES & ASSOCIATES, LLC | 282,961 | $16,955,023 | 1.08% |
| Chicago Capital, LLC | 360,345 | $21,591,884 | 1.01% |
| CARDINAL CAPITAL MANAGEMENT LLC /CT | 206,399 | $12,367,428 | 0.53% |
| Smith, Graham & Co., Investment Advisors, LP | 61,849 | $3,705,992 | 0.46% |
| Stephens Investment Management Group LLC | 467,564 | $28,016,435 | 0.46% |
| Jackson Creek Investment Advisors LLC | 13,657 | $818 | 0.34% |
| Court Place Advisors, LLC | 15,133 | $906,769 | 0.32% |
| Ziegler Capital Management, LLC | 123,158 | $7,379,176 | 0.30% |